RGS9BP
Basic information
Region (hg38): 19:32675848-32678300
Links
Phenotypes
GenCC
Source:
- bradyopsia (Strong), mode of inheritance: AR
- bradyopsia (Supportive), mode of inheritance: AR
- bradyopsia (Definitive), mode of inheritance: AR
- bradyopsia (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Prolonged electroretinal response suppression 2 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 14702087 |
ClinVar
This is a list of variants' phenotypes submitted to
- Prolonged electroretinal response suppression 2 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RGS9BP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 57 | 63 | ||||
missense | 75 | 79 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 10 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 1 | 0 | 95 | 59 | 5 |
Variants in RGS9BP
This is a list of pathogenic ClinVar variants found in the RGS9BP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-32676278-G-A | Likely benign (Feb 02, 2022) | |||
19-32676292-T-A | Uncertain significance (Jan 02, 2024) | |||
19-32676292-T-C | Uncertain significance (May 28, 2022) | |||
19-32676293-G-A | RGS9BP-related disorder | Benign (Jan 22, 2024) | ||
19-32676298-G-T | Uncertain significance (Nov 22, 2022) | |||
19-32676299-G-A | Likely benign (Apr 22, 2021) | |||
19-32676302-C-G | not specified | Benign (Jan 31, 2024) | ||
19-32676309-AC-A | Uncertain significance (Oct 13, 2022) | |||
19-32676311-G-A | RGS9BP-related disorder | Likely benign (Jul 27, 2021) | ||
19-32676314-T-G | Likely benign (Dec 18, 2023) | |||
19-32676330-C-A | Uncertain significance (Nov 08, 2022) | |||
19-32676335-G-A | Likely benign (Apr 09, 2021) | |||
19-32676355-CGGACTCGCA-C | Prolonged electroretinal response suppression 2 | drug response (Apr 24, 2023) | ||
19-32676359-C-G | Conflicting classifications of pathogenicity (Sep 08, 2023) | |||
19-32676363-C-T | Uncertain significance (Feb 27, 2022) | |||
19-32676368-C-T | Likely benign (Aug 10, 2023) | |||
19-32676370-T-TGCGGCAGGAGCTGCAAAAGAC | Uncertain significance (Jun 20, 2022) | |||
19-32676375-C-G | Uncertain significance (Aug 31, 2022) | |||
19-32676381-C-T | Likely benign (Apr 24, 2023) | |||
19-32676383-G-T | Likely benign (Jul 25, 2023) | |||
19-32676389-G-C | Uncertain significance (Jan 22, 2024) | |||
19-32676398-G-C | Uncertain significance (May 23, 2023) | |||
19-32676401-G-A | Likely benign (Oct 11, 2023) | |||
19-32676402-G-T | Uncertain significance (May 19, 2023) | |||
19-32676407-G-A | Likely benign (Feb 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RGS9BP | protein_coding | protein_coding | ENST00000334176 | 1 | 2894 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00232 | 0.549 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.675 | 110 | 132 | 0.835 | 0.00000598 | 1416 |
Missense in Polyphen | 24 | 41.115 | 0.58373 | 462 | ||
Synonymous | 1.21 | 55 | 67.6 | 0.813 | 0.00000323 | 548 |
Loss of Function | 0.250 | 4 | 4.58 | 0.874 | 1.97e-7 | 46 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulator of G protein-coupled receptor (GPCR) signaling in phototransduction. Participates in the recovery phase of visual transduction via its interaction with RGS9-1 isoform. Acts as a membrane-anchor that mediates the targeting of RGS9-1 to the photoreceptor outer segment, where phototransduction takes place. Enhances the ability of RGS9-1 to stimulate G protein GTPase activity, allowing the visual signal to be terminated on the physiologically time scale. It also controls the proteolytic stability of RGS9-1, probably by protecting it from degradation (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Prolonged electroretinal response suppression (PERRS) [MIM:608415]: Characterized by difficulty adjusting to sudden changes in luminance levels mediated by cones. {ECO:0000269|PubMed:14702087}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Signaling by GPCR;Signal Transduction;Visual signal transduction: Rods;G alpha (i) signalling events;Inactivation, recovery and regulation of the phototransduction cascade;The phototransduction cascade;Visual phototransduction;GPCR downstream signalling;Visual signal transduction: Cones
(Consensus)
Recessive Scores
- pRec
- 0.123
Haploinsufficiency Scores
- pHI
- 0.163
- hipred
- Y
- hipred_score
- 0.546
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.519
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rgs9bp
- Phenotype
- vision/eye phenotype;
Gene ontology
- Biological process
- negative regulation of signal transduction;detection of light stimulus involved in visual perception
- Cellular component
- photoreceptor outer segment;integral component of membrane
- Molecular function